Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.
about
Exercise-based cardiac rehabilitation for adults with atrial fibrillationOral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonistsSilent atrial fibrillation: epidemiology, diagnosis, and clinical impact.Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.Indications for the use of diagnostic implantable and external ECG loop recorders.Atrial fibrillation: state of the art.Can we improve outcomes in AF patients by early therapy?Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Detection of paroxysmal atrial fibrillation or flutter in patients with acute ischemic stroke or transient ischemic attack by Holter monitoring.The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissueTrends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice.U22 protocol as measure of symptomatic improvement after catheter ablation of atrial fibrillationExercise-based cardiac rehabilitation for adults with atrial fibrillation.Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.Performance of an implantable automatic atrial fibrillation detection device: impact of software adjustments and relevance of manual episode analysisExcessive supraventricular ectopic activity is indicative of paroxysmal atrial fibrillation in patients with cerebral ischemiaQuality of life, activity impairment, and healthcare resource utilization associated with atrial fibrillation in the US National Health and Wellness Survey.Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study.Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.Long-term success and follow-up after atrial fibrillation ablation.The effect of integrated cardiac rehabilitation versus treatment as usual for atrial fibrillation patients treated with ablation: the randomised CopenHeartRFA trial protocol.Effectiveness and safety of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation.The effect of a dual or a triple antithrombotic therapy with apixaban on thrombus formation in vivo and in an ex vivo perfusion chamber model: An open-label, controlled, sequential study.Association Between Rs3807989 Polymorphism in Caveolin-1 (CAV1) Gene and Atrial Fibrillation: A Meta-Analysis.Exploring the Potential Role of Catheter Ablation in Patients with Asymptomatic Atrial Fibrillation: Should We Move away from Symptom Relief?Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.Upstream therapy of atrial fibrillation.Rhythm control strategies and the role of antiarrhythmic drugs in the management of atrial fibrillation: focus on clinical outcomes.The pharmaceutical pipeline for atrial fibrillation.Natural orifice translumenal endoscopic surgery (NOTES(®)): a technical review.Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope.Examining the safety of amiodarone.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial designVenice Chart international consensus document on atrial fibrillation ablation: 2011 update.Cardioversion in atrial fibrillation. Focus on recent-onset atrial fibrillation.Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review.
P2860
Q24195079-738C2925-955D-4449-A84D-BE22BC81E01AQ24647947-592E0BD9-2F93-4A7A-B8E9-B33AE21F4FAAQ30235384-651A17F4-DF4B-416A-8885-E867F237A260Q30559656-CC50D908-49C4-427B-AFC2-436EAA606CDEQ30663685-ADD83D36-F536-45D7-93AE-B3A6185AD133Q33157361-E72687E0-259F-405E-BF6E-8A73B77948C6Q33359459-B92D1FC5-844D-4FB6-B218-1734670021BDQ33516708-29A19FD0-31D8-4EEB-9C8E-7B62AC24A961Q33553902-A3884735-3DE0-4AB7-A01E-17DBC2EC510CQ33596831-1F4D3267-4DC6-432C-8D32-BCE9B928FD9DQ33806739-FBE6B132-CC03-4C1A-A90E-084CE8EDCCE7Q34062393-9EF5F1F4-F1DA-4FF8-9E48-E6261FD6CF80Q34307919-B46C7609-D710-447A-9881-00E5EBF82E6AQ34311156-51252103-DFEF-4466-844F-296FF47628C3Q34550885-4C0E5D3D-C8CB-4F50-B4F6-A8EC750686D6Q34609020-D1AD356C-E487-461A-BCE6-E3697725B24AQ34731006-1ABD8D16-237E-4CBB-825E-0C6F8A8646ABQ34807752-4E89C75F-0286-4205-9B54-FF9404C2ABDBQ34949056-4C16D4B5-36C2-4FAB-ABB6-8297B0A152EBQ35454452-8F90BCAC-92DD-452B-835C-1BED9FD54591Q35609742-E22AC4AF-FF8C-4AED-BC7F-FDCCB74DC2ECQ36108848-A4A824D1-4D8C-4002-B09B-75C457296CD3Q36382385-060E766A-F18B-4617-B79F-BB41DCE7C5ABQ36650126-1CE7A6AA-6A62-4881-9C9F-9E65EDA1CAB9Q37222352-5F4CC056-60E2-4DE0-BDC0-A60F0533718CQ37328158-788378AA-CE01-40BF-99D4-06B7F33EF1BCQ37387813-3B4F7931-8061-4F79-84AD-7E4867B7552BQ37495738-27B3087B-9D65-4EB4-88F0-2C88EDB0E9B9Q37521378-F4472420-7C88-478B-B02A-68F35FD332B3Q37546133-64D6A4EA-C963-4D53-8EFC-A1F996EA42BDQ37812344-E0B282CA-F051-43AB-90BE-E026BC1AB495Q37821928-B571980C-307E-4AD9-8E73-3FBBF852F514Q37873385-31204517-713D-4EDD-85F4-66EF3594CAFBQ37947093-D9CFD70B-CFDB-4F06-A3A5-5B4B634AFC2FQ37983124-5CF2D4CE-2739-4995-AB23-1A8E5F48C91BQ37989837-6A437193-DF5D-44B7-831B-F5C1594EC1CDQ38041202-E972E102-AD55-4F80-B2A6-943307377F66Q38052849-61EE3CCD-30FC-4FE1-BB7D-5AAFD20DF747Q38069057-B2780C3A-A654-46BC-8690-1BF0C6821C3AQ38084661-8AE2B382-FCF1-4A8F-8DFD-C336287D68A5
P2860
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Outcome parameters for trials ...... pean Heart Rhythm Association.
@ast
Outcome parameters for trials ...... pean Heart Rhythm Association.
@en
Outcome parameters for trials ...... pean Heart Rhythm Association.
@nl
type
label
Outcome parameters for trials ...... pean Heart Rhythm Association.
@ast
Outcome parameters for trials ...... pean Heart Rhythm Association.
@en
Outcome parameters for trials ...... pean Heart Rhythm Association.
@nl
prefLabel
Outcome parameters for trials ...... pean Heart Rhythm Association.
@ast
Outcome parameters for trials ...... pean Heart Rhythm Association.
@en
Outcome parameters for trials ...... pean Heart Rhythm Association.
@nl
P2093
P50
P356
P1433
P1476
Outcome parameters for trials ...... pean Heart Rhythm Association.
@en
P2093
Alphons Vincent
Andreas Goette
Bertil Olsson
Elisabeth Svernhage
Gerd Hindricks
Gerhard Steinbeck
Harry Crijns
Jan Tijssen
Lukas Kappenberger
P304
P356
10.1093/EUROPACE/EUM191
P50
P577
2007-09-25T00:00:00Z